21304-Peritoneal Cancer-NA-580

Peritoneal Cancer

A Phase 1b, Multicenter Study to Determine the Dose, Safety, Efficacy and Pharmacokinetics of TRK-950 when Used in Combinations with Selected Anti-Cancer Treatment Regimens in Patients with Selected Advanced Solid Tumors.(950P1V02)

  • Details

ClinicalTrials.gov ID: NCT03872947
Diagnosis Type: NA
USOR Number:

  • Address

2070 W. Rudasill Rd., #130
Tucson, AZ 85704
P: (520) 797-4468

Search by practice name, trial titles, indicators and specific disease types.

Find a Location

With more than 2,500 physicians and over 600 treatment locations across the country, the advanced cancer care you need may be available right in your local community from a practice in The US Oncology Network. Search to see if there is a center near you.